In case anyone missed this presentation.
https://www.aats.org/resources/lb4-prospective-single-center-randomized-control-trial-to-evaluate-the-safety-and-feasibility-of-a-novel-allogenic-mesenchymal-precursor-cell-therapy-in-patients-with-hypoplastic-left-heart-syndrome-2
Doctors are impatient for this stem cell therapy for their patients… not my words but
rather the words from a doctor during question time.
Well done to Boston’s Children’s Hospital for trailblazing this new treatment… again a doctor’s words, not mine.
Bring on MSB’s Phase 3 trial
- Forums
- ASX - By Stock
- Ann: FDA Grants Rare Pediatric Disease Designation for Revascor
In case anyone missed this presentation....
- There are more pages in this discussion • 158 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.08 |
Change
-0.005(0.46%) |
Mkt cap ! $1.238B |
Open | High | Low | Value | Volume |
$1.07 | $1.09 | $1.05 | $1.023M | 955.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 11927 | $1.08 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.08 | 36810 | 15 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 11927 | 1.075 |
15 | 80713 | 1.070 |
16 | 101776 | 1.065 |
16 | 180954 | 1.060 |
13 | 183987 | 1.055 |
Price($) | Vol. | No. |
---|---|---|
1.080 | 36812 | 16 |
1.085 | 67390 | 13 |
1.090 | 201416 | 14 |
1.095 | 71661 | 7 |
1.100 | 93988 | 13 |
Last trade - 11.09am 12/06/2024 (20 minute delay) ? |
|
|||||
Last
$1.07 |
  |
Change
-0.005 ( 0.98 %) |
|||
Open | High | Low | Volume | ||
$1.07 | $1.09 | $1.06 | 194927 | ||
Last updated 11.26am 12/06/2024 ? |
Featured News
MSB (ASX) Chart |